Abstract:Down syndrome (DS) is the most common cause of early-onset Alzheimers disease (AD). Dietary choline has been proposed as a modifiable factor to improve cognitive and pathological outcomes of AD, especially as many do not reach adequate daily intake levels. Perinatal choline supplementation (Ch+) in the Ts65Dn mouse model of DS protects offspring against AD-relevant pathology and improves cognition, and dietary Ch+ in adult AD models also ameliorates pathology and improves cognition. However, dietary Ch+ in adult Ts65Dn mice has not yet been explored. To test whether Ch+ in adulthood improves DS co-morbidities, we fed trisomic Ts65Dn mice and disomic littermate controls with either choline normal (ChN; 1.1 g/kg) or Ch+ (5 g/kg) diets from 4.5-14 months of age. We found that Ch+ improved cognitive flexibility in a reverse place preference task and reduced weight gain and peripheral inflammation in female mice, whereas Ch+ improved glucose metabolism in male mice. In conclusion, we found that adulthood Ch+ benefits behavioral and biological factors important for general well-being in DS and related to AD risk.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the effect of choline supplementation during adulthood on mouse models of Down syndrome (DS). Specifically, the study aims to explore whether choline supplementation during adulthood can improve DS - related comorbid symptoms and enhance cognitive function. The paper focuses on the following aspects: 1. **Weight change**: Evaluate the effect of choline supplementation on weight gain and loss in mice of different genders. 2. **Metabolic indicators**: Detect the effect of choline supplementation on blood - glucose metabolism and peripheral inflammation. 3. **Cognitive function**: Evaluate the effect of choline supplementation on cognitive flexibility and spatial memory through multiple behavioral tests (such as rotarod test, radial - arm water maze, IntelliCage test). ### Main research background - **Down syndrome and Alzheimer's disease**: Patients with Down syndrome are a high - risk group for early - onset Alzheimer's disease. Almost all Down syndrome patients will show the pathological features of Alzheimer's disease between the ages of 40 and 50. - **The role of choline**: Choline is an important precursor for the synthesis of acetylcholine, which is involved in learning, memory, and executive functions in the brain. Studies have shown that insufficient choline intake will exacerbate the pathological process of Alzheimer's disease. - **Previous research**: Previous studies have mainly focused on choline supplementation during pregnancy and lactation and found that these supplements can prevent neurodegenerative diseases in offspring and improve cognitive function. However, the effect of choline supplementation during adulthood has not been fully explored. ### Research purposes - **Verify the effect of choline supplementation during adulthood**: The study hypothesizes that choline supplementation during adulthood may be beneficial to the comorbid symptoms and cognitive function of Down syndrome patients. - **Evaluate gender differences**: Explore whether there are differences in the effect of choline supplementation in mice of different genders. ### Experimental design - **Animal model**: Use Ts65Dn mice as a Down syndrome model, divided into trisomic (3n) and disomic (2n) control groups. - **Dietary intervention**: Starting from 4.5 months of age, normal - choline diet (ChN, 1.1 g/kg) and high - choline diet (Ch +, 5 g/kg) were given respectively, and continued until 14 months of age. - **Behavioral tests**: Include rotarod test, radial - arm water maze test, and IntelliCage test to evaluate motor function, spatial memory, and cognitive flexibility. - **Metabolic indicators**: Measure body weight, blood - glucose level, and peripheral inflammation markers. ### Main findings - **Weight change**: Choline supplementation significantly reduced the weight gain in female mice, but had no effect on male mice. - **Metabolic indicators**: Choline supplementation decreased the fasting blood - glucose level in male mice and improved blood - glucose metabolism. - **Cognitive function**: Choline supplementation improved the cognitive flexibility in female mice, but had no significant effect on spatial memory. ### Conclusion Choline supplementation during adulthood has a positive impact on body weight, blood - glucose metabolism, and cognitive flexibility in mouse models of Down syndrome, especially more obvious in female mice. These results support choline supplementation as a potential early - intervention measure to reduce the risk of Down syndrome patients developing Alzheimer's disease.

Adult choline supplementation in a Down syndrome model reduces co-morbidities and improves cognition

Assessing the Benefit of Dietary Choline Supplementation Throughout Adulthood in the Ts65Dn Mouse Model of Down Syndrome

Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease

Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer's disease

Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer’s disease

Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease

Choline Supplementation Ameliorates Behavioral Deficits and Alzheimer's Disease-Like Pathology in Transgenic APP/PS1 Mice

Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Aβ42 deposition in App NL-G-F Alzheimer's disease model mice

CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation

Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.

Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer's Disease

Neuroprotective Actions of Dietary Choline

Prenatal choline supplementation attenuates MK-801-induced deficits in memory, motor function, and hippocampal plasticity in adult male rats

Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice

The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice

Lithium carbonate treatment decrease neuroinflammation and ameliorates long‐term memory in a Down syndrome animal model

Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [ F]-Fluoroethoxybenzovesamicol Positron Emission Tomography Imaging

Maternal Choline Supplementation Supports Resistance to Effects of Prolonged Western Diet Feeding in Mice Offspring

Maternal choline supplementation modulates cognition and induces anti-inflammatory signaling in the prefrontal cortices of adolescent rats exposed to maternal immune activation

Choline Supplementation Alters Hippocampal Cytokine Levels in Adolescence and Adulthood in an Animal Model of Fetal Alcohol Spectrum Disorders

Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes